Content about Janet Woodcock

March 19, 2013

FDA picks acting director for Office of Generic Drugs

The Food and Drug Administration has picked Kathleen Uhl to serve as acting director of the Office of Generic Drugs, the agency said.

March 22, 2012

FDA opens dialogue of incorporating technology, pharmacy into switch paradigm

The Food and Drug Administration's director of the Center for Drug Evaluation and Research, Janet Woodcock, on Thursday identified three tools the agency wanted to use in potentially increasing access to appropriate medicines in her opening remarks at the FDA Rx-to-OTC Switch Hearing.

May 10, 2011

Report: Number of drug approvals by FDA may increase

The Food and Drug Administration expects to approve an increasing number of drugs, according to published reports.

November 14, 2010

FDA generic user fees moving closer to reality

A backlog of more than 2,000 drug entities and devices is awaiting approval. That’s the...

November 14, 2010

GPhA responds to possibility of more stringent FDA regulations

A ghost from 2008 soon could come back to haunt 2010....

October 20, 2010

Report: FDA may consider strengthening generic drug regulations

The Food and Drug Administration could decide that some generic drugs are not equivalent to...